Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Salvatore Di Maio, Stephen Yip, Gmaan A Al Zhrani, Fahad E Alotaibi, Abdulrahman Al Turki, Esther Kong & Robert C Rostomily. (2015) Novel targeted therapies in chordoma: an update. Therapeutics and Clinical Risk Management 11, pages 873-883.
Read now
Read now
Hongsheng Wang, Qingbo Yang, Zeze Fu, Dongqing Zuo, Yingqi Hua & Zhengdong Cai. (2014) ErbB Receptors as Prognostic and Therapeutic Drug Targets in Bone and Soft Tissue Sarcomas. Cancer Investigation 32:10, pages 533-542.
Read now
Read now
T. Asklund, M. Sandström, S. Shahidi, K. Riklund & R. Henriksson. (2014) Durable stabilization of three chordoma cases by bevacizumab and erlotinib. Acta Oncologica 53:7, pages 980-984.
Read now
Read now
Matthias Uhl & Jürgen Debus. (2014) Chordoma: an assessment of future treatment and management strategies. Expert Opinion on Orphan Drugs 2:6, pages 557-565.
Read now
Read now
Articles from other publishers (54)
Yu Xiao, Wenlong Yu, Jianhu Zheng, Lin Cheng, Xing Ding, Liang Qiao, Xuequn Wu & Junming Ma. (2023) Bibliometric Insights in Advances of Chordoma: Global Trends and Research Development in the Last Decade. Orthopaedic Surgery 15:10, pages 2505-2514.
Crossref
Crossref
Benjamin J. Lee, Audrey Grossen, Helen Shi, Sara Abu Mehsen, Zhongxin Yu, Kar-Ming A. Fung, Khairuddin Memon & Joanna E. Gernsback. (2023) Review of Pediatric Extraosseous Chordomas with a Unique, Illustrative Case. Pediatric Neurosurgery 58:1, pages 29-37.
Crossref
Crossref
Thibault Passeri, Ahmed Dahmani, Julien Masliah-Planchon, Rania El Botty, Laura Courtois, Sophie Vacher, Elisabetta Marangoni, Fariba Nemati, Sergio Roman-Roman, Homa Adle-Biassette, Hamid Mammar, Sébastien Froelich, Ivan Bièche & Didier Decaudin. (2022) In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts. Frontiers in Oncology 12.
Crossref
Crossref
Kurtis Young, Torbjoern Nielsen, Hannah Bulosan, Tyler J. Thorne, Christian T. Ogasawara, Andrew C. Birkeland, Dennis M. Tang, Arthur W. Wu & Toby O. Steele. (2022) Metastatic skull base chordoma: A systematic review. Laryngoscope Investigative Otolaryngology 7:5, pages 1280-1291.
Crossref
Crossref
K. Mellert, C. Seeling, P. Möller & T. F. E. Barth. (2022) Chordome – Ein UpdateChordoma—An update. Die Pathologie 43:S1, pages 50-55.
Crossref
Crossref
Dan Xiao, Yongxiong Huang, Shuaihao Huang, Jianxiong Zhuang, P. Chen, Yi Wang & Lei Zhang. (2022) Targeted delivery of cancer drug paclitaxel to chordomas tumor cells via an RNA nanoparticle harboring an EGFR aptamer. Colloids and Surfaces B: Biointerfaces 212, pages 112366.
Crossref
Crossref
Giacomo G. Baldi, Salvatore Lo Vullo, Giovanni Grignani, Bruno Vincenzi, Giuseppe Badalamenti, Marinella Mastore, Ciriaco Buonomenna, Carlo Morosi, Marta Barisella, Anna Maria Frezza, Salvatore Provenzano, Noemi Simeone, Fernanda Picozzi, Luigi Mariani, Paolo G. Casali & Silvia Stacchiotti. (2022) Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network. Cancer 128:7, pages 1439-1448.
Crossref
Crossref
Ahmad Al Shihabi, Ardalan Davarifar, Huyen Thi Lam Nguyen, Nasrin TavanaieScott D. Nelson, Jane YanagawaNoah FedermanNicholas Bernthal, Francis HornicekAlice Soragni. (2022) Personalized chordoma organoids for drug discovery studies. Science Advances 8:7.
Crossref
Crossref
Tianna Zhao, I‐Mei Siu, Tara Williamson, Haoyu Zhang, Chenchen Ji, Peter C Burger, Nick Connis, Jacob Ruzevick, Menghang Xia, Lucia Cottone, Adrienne M Flanagan, Christine L Hann & Gary L Gallia. (2021)
AZD8055
enhances
in vivo
efficacy of afatinib in chordomas
. The Journal of Pathology 255:1, pages 72-83.
Crossref
Crossref
Scott Raskin & Miriam Bornhorst. (2021) Biological Treatments of Neurofibromatosis Type 2 and Other Skull Base Disorders. Otolaryngologic Clinics of North America 54:4, pages 789-801.
Crossref
Crossref
Mary Frances Wedekind, Brigitte C. Widemann & Gregory Cote. (2021) Chordoma: Current status, problems, and future directions. Current Problems in Cancer 45:4, pages 100771.
Crossref
Crossref
M. Ronai & P.P. Varga. (2021) Cordoma. EMC - Aparato Locomotor 54:1, pages 1-8.
Crossref
Crossref
Daniel J. Zabransky, Zach Pennington & Christian Meyer. 2021. Chordoma of the Spine. Chordoma of the Spine
289
304
.
Saurav Verma, Surya Prakash Vadlamani, Shamim Ahmed Shamim, Adarsh Barwad, Sameer Rastogi & S. T. Arun Raj. (2020) Partial response to erlotinib in a patient with imatinib-refractory sacral chordoma. Clinical Sarcoma Research 10:1.
Crossref
Crossref
Corey M Gill, Mary Fowkes & Raj K Shrivastava. (2020) Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era. Neurosurgery 86:2, pages E118-E123.
Crossref
Crossref
Benoîte Méry, Elise Rowinski, Mathilde Guinand, Marouan Benna, Amal Bousarsar, Claire Bosacki, Alexis Vallard & Nicolas Magné. (2020) Depuis la recherche translationnelle jusqu’aux nouveaux paradigmes thérapeutiques : mise à jour des données dans les chordomes. Bulletin du Cancer 107:1, pages 129-135.
Crossref
Crossref
Anna Maria Frezza, Laura Botta, Annalisa Trama, Angelo P. Dei Tos & Silvia Stacchiotti. (2019) Chordoma: update on disease, epidemiology, biology and medical therapies. Current Opinion in Oncology 31:2, pages 114-120.
Crossref
Crossref
Tong Meng, Jiali Jin, Cong Jiang, Runzhi Huang, Huabin Yin, Dianwen Song & Liming Cheng. (2019) Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic Review. Frontiers in Oncology 9.
Crossref
Crossref
Rika Fujii, Jeffrey Schlom & James W. Hodge. (2018) A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab. Journal of Neurosurgery 128:5, pages 1419-1427.
Crossref
Crossref
Paola Magnaghi, Barbara Salom, Liviana Cozzi, Nadia Amboldi, Dario Ballinari, Elena Tamborini, Fabio Gasparri, Alessia Montagnoli, Laura Raddrizzani, Alessio Somaschini, Roberta Bosotti, Christian Orrenius, Fabio Bozzi, Silvana Pilotti, Arturo Galvani, Josh Sommer, Silvia Stacchiotti & Antonella Isacchi. (2018) Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury. Molecular Cancer Therapeutics 17:3, pages 603-613.
Crossref
Crossref
A. von Witzleben, K. Mellert, P. Möller & T. F. E. Barth. (2018) Neue diagnostische und therapeutische Aspekte zu ChordomenNovel diagnostic and therapeutic aspects on chordomas. Der Onkologe 24:3, pages 199-207.
Crossref
Crossref
Elizabeth J. Davis, Rashmi Chugh & Scott M. Schuetze. 2018. Chordomas and Chondrosarcomas of the Skull Base and Spine. Chordomas and Chondrosarcomas of the Skull Base and Spine
399
409
.
Takehiko Yamaguchi, Hiroki Imada, Shun Iida & Karoly Szuhai. (2017) Notochordal Tumors. Surgical Pathology Clinics 10:3, pages 637-656.
Crossref
Crossref
Vittoria Colia & Silvia Stacchiotti. (2017) Medical treatment of advanced chordomas. European Journal of Cancer 83, pages 220-228.
Crossref
Crossref
S. Stacchiotti, A. Gronchi, P. Fossati, T. Akiyama, C. Alapetite, M. Baumann, J.Y. Blay, S. Bolle, S. Boriani, P. Bruzzi, R. Capanna, A. Caraceni, R. Casadei, V. Colia, J. Debus, T. Delaney, A. Desai, P. Dileo, S. Dijkstra, F. Doglietto, A. Flanagan, S. Froelich, P.A. Gardner, H. Gelderblom, Z.L. Gokaslan, R. Haas, C. Heery, N. Hindi, P. Hohenberger, F. Hornicek, R. Imai, L. Jeys, R.L. Jones, B. Kasper, A. Kawai, M. Krengli, A. Leithner, I. Logowska, J. Martin Broto, D. Mazzatenta, C. Morosi, P. Nicolai, O.J. Norum, S. Patel, N. Penel, P. Picci, S. Pilotti, S. Radaelli, F. Ricchini, P. Rutkowski, S. Scheipl, C. Sen, E. Tamborini, K.A. Thornton, B. Timmermann, V. Torri, P.U. Tunn, M. Uhl, Y. Yamada, D.C. Weber, D. Vanel, P.P. Varga, C.L.A. Vleggeert-Lankamp, P.G. Casali & J. Sommer. (2017) Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group. Annals of Oncology 28:6, pages 1230-1242.
Crossref
Crossref
Martin J. RutkowskiHarjus S. BirkMatthew D. Wood, Arie Perry, Theodore Nicolaides, Christopher P. AmesNalin Gupta. (2017) Metastatic clival chordoma: a case report of multiple extraneural metastases following resection and proton beam radiotherapy in a 5-year old boy. Journal of Neurosurgery: Pediatrics 19:5, pages 531-537.
Crossref
Crossref
Yohei Kitamura, Hikaru Sasaki & Kazunari Yoshida. (2017) Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma. Brain Tumor Pathology 34:2, pages 78-90.
Crossref
Crossref
Astrid Lipplaa, Sander Dijkstra & Hans Gelderblom. (2016) Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series. Clinical Sarcoma Research 6:1.
Crossref
Crossref
David C. Portnoy & Ari M. VanderWalde. (2016) Systemic therapy for bone sarcomas. Current Orthopaedic Practice 27:6, pages 587-592.
Crossref
Crossref
Susanne Scheipl, Michelle Barnard, Lucia Cottone, Mette Jorgensen, David H Drewry, William J Zuercher, Fabrice Turlais, Hongtao Ye, Ana P Leite, James A Smith, Andreas Leithner, Peter Möller, Silke Brüderlein, Naomi Guppy, Fernanda Amary, Roberto Tirabosco, Sandra J Strauss, Nischalan Pillay & Adrienne M Flanagan. (2016) EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen. The Journal of Pathology 239:3, pages 320-334.
Crossref
Crossref
Christopher R. Heery. (2016) Chordoma: The Quest for Better Treatment Options. Oncology and Therapy 4:1, pages 35-51.
Crossref
Crossref
Tamara Aleksic, Lisa Browning, Martha Woodward, Rachel Phillips, Suzanne Page, Shirley Henderson, Nicholas Athanasou, Olaf Ansorge, Duncan Whitwell, Sarah Pratap, A. Bassim Hassan, Mark R. Middleton & Valentine M. Macaulay. (2016) Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR. Frontiers in Oncology 6.
Crossref
Crossref
Adrian von Witzleben, Lukas T. Goerttler, Ralf Marienfeld, Holger Barth, André Lechel, Kevin Mellert, Michael Böhm, Marko Kornmann, Regine Mayer-Steinacker, Alexandra von Baer, Markus Schultheiss, Adrienne M. Flanagan, Peter Möller, Silke Brüderlein & Thomas F.E. Barth. (2015) Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway. Cancer Research 75:18, pages 3823-3831.
Crossref
Crossref
Loïc Lebellec, Sébastien Aubert, Fahed Zaïri, Thomas Ryckewaert, Bruno Chauffert & Nicolas Penel. (2015) Molecular targeted therapies in advanced or metastatic chordoma patients: Facts and hypotheses. Critical Reviews in Oncology/Hematology 95:1, pages 125-131.
Crossref
Crossref
Raewyn G. Campbell, Daniel M. Prevedello, Leo Ditzel Filho, Brad A. Otto & Ricardo L. Carrau. (2015) Contemporary management of clival chordomas. Current Opinion in Otolaryngology & Head and Neck Surgery 23:2, pages 153-161.
Crossref
Crossref
Silvia Stacchiotti & Josh Sommer. (2015) Building a global consensus approach to chordoma: a position paper from the medical and patient community. The Lancet Oncology 16:2, pages e71-e83.
Crossref
Crossref
R. Akhavan-Sigari, M. Abili, M. R. Gaab, V. Rohde, N. Zafar, P. Emami & H. Ostertag. (2014) Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma. Neurosurgical Review 38:1, pages 89-99.
Crossref
Crossref
Reza Akhavan-Sigari, Michael Robert Gaab, Veit Rohde, Mehdi Abili & Helmut Ostertag. (2014) Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma. European Spine Journal 23:11, pages 2416-2422.
Crossref
Crossref
B. George, D. Bresson, S. Bouazza, S. Froelich, E. Mandonnet, S. Hamdi, M. Orabi, M. Polivka, A. Cazorla, H. Adle-Biassette, J.-P. Guichard, M. Duet, E. Gayat, F. Vallée, C.-H. Canova, F. Riet, S. Bolle, V. Calugaru, R. Dendale, J.-J. Mazeron, L. Feuvret, E. Boissier, S. Vignot, S. Puget, C. Sainte-Rose & K. Beccaria. (2014) Les chordomes. Neurochirurgie 60:3, pages 63-140.
Crossref
Crossref
Taohui Ouyang, Na Zhang, Yan Zhang, Jiantong Jiao, Jian Ren, Tao Huang & Jian Chen. (2014) Clinical Characteristics, Immunohistochemistry, and Outcomes of 77 Patients with Skull Base Chordomas. World Neurosurgery 81:5-6, pages 790-797.
Crossref
Crossref
R. Yadav, M. C. Sharma, P. B. Malgulwar, P. Pathak, E. Sigamani, V. Suri, C. Sarkar, A. Kumar, M. Singh, B. S. Sharma, A. Garg, S. Bakhshi & M. Faruq. (2013) Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas. Neuro-Oncology 16:3, pages 372-381.
Crossref
Crossref
I-Mei Siu, Jacob Ruzevick, Qi Zhao, Nick Connis, Yuchen Jiao, Chetan Bettegowda, Xuewei Xia, Peter C. Burger, Christine L. Hann & Gary L. Gallia. (2013) Erlotinib Inhibits Growth of a Patient-Derived Chordoma Xenograft. PLoS ONE 8:11, pages e78895.
Crossref
Crossref
Yoshiya Yamada, Mrinal Gounder & Ilya Laufer. (2013) Multidisciplinary Management of Recurrent Chordomas. Current Treatment Options in Oncology 14:3, pages 442-453.
Crossref
Crossref
S. Stacchiotti, E. Tamborini, S. Lo Vullo, F. Bozzi, A. Messina, C. Morosi, A. Casale, F. Crippa, E. Conca, T. Negri, E. Palassini, A. Marrari, E. Palmerini, L. Mariani, A. Gronchi, S. Pilotti & P.G. Casali. (2013) Phase II study on lapatinib in advanced EGFR-positive chordoma. Annals of Oncology 24:7, pages 1931-1936.
Crossref
Crossref
Silvia StacchiottiAlessandra LonghiVirginia FerraresiGiovanni GrignaniAlessandro ComandoneRoger StuppAlexia BertuzziElena TamboriniSilvana PilottiAntonella MessinaCarlo SpreaficoAlessandro GronchiPaola AmoreVincenza VinacciaPaolo Giovanni Casali. (2012) Phase II Study of Imatinib in Advanced Chordoma. Journal of Clinical Oncology 30:9, pages 914-920.
Crossref
Crossref
Hannes Vogel. (2012) Chordoma. Pathology Case Reviews 17:1, pages 31-38.
Crossref
Crossref
Simon G Launay, Bruno Chetaille, Fanny Medina, Delphine Perrot, Serge Nazarian, Jérôme Guiramand, Laurence Moureau-Zabotto & François Bertucci. (2011) Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review. BMC Cancer 11:1.
Crossref
Crossref
Roberto Jose Diaz & Michael D. Cusimano. (2011) The biological basis for modern treatment of chordoma. Journal of Neuro-Oncology 104:2, pages 411-422.
Crossref
Crossref
Silvia Stacchiotti & Paolo Giovanni Casali. (2011) Systemic Therapy Options for Unresectable and Metastatic Chordomas. Current Oncology Reports 13:4, pages 323-330.
Crossref
Crossref
Asem Shalaby, Nadège Presneau, Hongtao Ye, Dina Halai, Fitim Berisha, Bernadine Idowu, Andreas Leithner, Bernadette Liegl, Timothy RW Briggs, Krisztian Bacsi, Lars-Gunnar Kindblom, Nicholas Athanasou, Maria Fernanda Amary, Pancras CW Hogendoorn, Roberto Tirabosco & Adrienne M Flanagan. (2011) The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. The Journal of Pathology 223:3, pages 336-346.
Crossref
Crossref
Jeffrey J Barry, Brian J Jian, Michael E Sughrue, Ari J Kane, Steven A Mills, Tarik Tihan & Andrew T Parsa. (2011) The Next Step: Innovative Molecular Targeted Therapies for Treatment of Intracranial Chordoma Patients. Neurosurgery 68:1, pages 231-241.
Crossref
Crossref
E. Tamborini, E. Virdis, T. Negri, M. Orsenigo, S. Brich, E. Conca, A. Gronchi, S. Stacchiotti, G. Manenti, P. G. Casali, M. A. Pierotti & S. Pilotti. (2010) Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas. Neuro-Oncology 12:8, pages 776-789.
Crossref
Crossref
Marco A. Pierotti, Tiziana Negri, Elena Tamborini, Federica Perrone, Sabrina Pricl & Silvana Pilotti. (2009) Targeted Therapies: The Rare Cancer Paradigm. Molecular Oncology 4:1, pages 19-37.
Crossref
Crossref
Silvia Stacchiotti, Paolo Giovanni Casali, Salvatore Lo Vullo, Luigi Mariani, Elena Palassini, Mario Mercuri, Marco Alberghini, Silvana Pilotti, Licciana Zanella, Alessandro Gronchi & Piero Picci. (2009) Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers. Annals of Surgical Oncology 17:1, pages 211-219.
Crossref
Crossref